ID: ALA44375

Max Phase: Preclinical

Molecular Formula: C21H14O4

Molecular Weight: 330.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccccc1)c1cc(O)c2c(c1)Cc1cccc(O)c1C2=O

Standard InChI:  InChI=1S/C21H14O4/c22-16-8-4-7-13-9-14-10-15(20(24)12-5-2-1-3-6-12)11-17(23)19(14)21(25)18(13)16/h1-8,10-11,22-23H,9H2

Standard InChI Key:  ZTZNKBVGHRNWCH-UHFFFAOYSA-N

Associated Targets(non-human)

Arachidonate 5-lipoxygenase 259 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 330.34Molecular Weight (Monoisotopic): 330.0892AlogP: 3.46#Rotatable Bonds: 2
Polar Surface Area: 74.60Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.06CX Basic pKa: CX LogP: 5.70CX LogD: 5.62
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: 0.71

References

1. Müller K, Leukel P, Ziereis K, Gawlik I..  (1994)  Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.,  37  (11): [PMID:8201600] [10.1021/jm00037a017]

Source